22 funding opportunities found in this category. Change the order of results: Newest First Oldest First Expiring Soonest Expiring Latest Lowest Award to Highest Highest Award to Lowest
Barth Syndrome Foundation 2013 Request for Research Proposals
The Barth Syndrome Foundation, Inc. (BSF) and its international affiliates are pleased to announce the availability of funding for basic science and clinical research on the natural history, biochemical basis, and treatment of Barth syndrome. Starting in 2013, there will be two types of grant awards: IDEA grants for 1-2 years and DEVELOPMENT grants for 2-3 years with budgetary maximums of US $50,000 or $100,000, respectively over the full period. BSF's Research Grant Program allows young, non-tenured investigators to include in their submitted budget up to 75% of the direct costs amount as PI salary (10% for established investigators). In addition, for those clinical applications where volunteers must travel to a clinical research site, these travel expenses will be handled separately and will not be included in the application budget limitation. We encourage all investigators at every professional level to submit their best ideas for advancing the state of knowledge about Barth syndrome so that progress can be made in finding a specific treatment or a cure for this unusual mitochondrial disease. There are no geographical limitations to this funding.
Barth syndrome (BTHS) is a serious X-linked genetic condition associated with cardiomyopathy, neutropenia, skeletal muscle weakness, exercise intolerance, growth delay, and diverse biochemical abnormalities (including defects in mitochondrial metabolism and phospholipid biosynthesis). Because many clinical and biochemical abnormalities of Barth syndrome remain poorly understood, we are seeking proposals for both basic science and clinical research that may shed light on any aspect of the syndrome, with the ultimate objective of developing a specific treatment or a cure.
Types of Proposals Sought
We are interested in providing financial assistance to investigators interested in exploring the field of BTHS science and/or clinical research. We anticipate that these funds might be useful as “seed grants” for the testing of initial hypotheses and the collection of preliminary data that can lead to successful long-term funding by the National Institutes of Health (NIH) and other major granting institutions around the world. In addition to those having prior research experience with BTHS, we encourage young investigators and experienced investigators that are new to the field of BTHS to submit proposals for funding.
Process
We have a competitive grant process. Applications should be of 10–15 pages in length and must follow the instructions listed on the BSF website. In general terms, detailed information about the specific aims, significance, research design and methods, personnel, facilities, and budget will be required. A one-page, “Letter of Intent” is required for DEVELOPMENT grant applicants with a due date of September 1, 2013. The “Letter of Intent” is optional for IDEA grant applicants. We strongly encourage the submission of letters of intent before the due date to allow ample time for review and feedback.
Completed applications (and/or “Letters of Intent”) will be forwarded to the BSF Scientific and Medical Advisory Board (as well as to expert outside reviewers) for confidential evaluation. Response to the “Letter of Intent” will be communicated within two weeks of receipt. Based on the recommendations of the BSF Scientific and Medical Advisory Board, the BSF Board of Directors will make the final funding decisions about the grant applications. Please review our “Grants Awarded” webpage for a listing of grants that BSF and its affiliates have awarded to date.
Funding
We anticipate awarding several IDEA and DEVELOPMENT grants each year. Funds will be available soon after the successful grant applicants have been notified in early March, 2014.
Deadline
The deadline for submission of the completed research grant application is October 31, 2013, and grants will be awarded in early March, 2014. The deadline for the one-page "Letter of Intent," if applicable, is September 1, 2013.
Contact Information
Matthew J. Toth, PhD Science Director Barth Syndrome Foundation, Inc. matthew.toth[at]barthsyndrome.org mtothbsf[at]comcast.net bsfinfo[at]barthsyndrome.org
Vasculitis Foundation Research Program Awards
The purpose of the Vasculitis Foundation Research Program is to provide one- or two-year seed grants to support pilot studies in researching the:
• etiology
• epidemiology
• diagnosis
• treatment, including approaches that would prevent complications, and development of coping skills for living with this disease
The goals of the Research Program are to improve the quality of life for patients with vasculitis and ultimately find the cause/s and cure for vasculitis.
The Research Program is funded by donations and special fundraising events.
Maximum awards will be $50,000 for 12 months. Some awards will be available for two years. The Foundation’s hope is that the results of the research supported by the Research Program will lead to, and provide the basis for, much larger multi-year studies that would be funded by larger agencies such as The National Institutes of Health.
Applications are reviewed annually. The deadline for submitting applications for the 2013 funding cycle is Friday, August 2, 2013.
International Society of Nurses in Genetics Nursing Research Grant Program
The purpose of the annual ISONG Nursing Research Grant award is to support research related to genetic/genomic nursing practice or to the development of genetic/genomic nursing science. Grant funding may be used as "seed" money for conducting a pilot study or for support of an ongoing research investigation with promising contribution to genetic/genomic nursing science and genetic nursing practice. All relevant research areas will be considered; however, priority will be given to studies that address genetic/genomic nursing practice or genetic/genomic health outcomes. Awarding of grant funding is competitive and will be determined through peer review of proposals by members of the ISONG Research Committee.
ISONG is pleased to announce that for the 2013-2014 funding cycle, the University of Pittsburgh School of Nursing will support one $1500 grant and Johns Hopkins University will support one $2000 grant. Each grant will be for a period of up to 12 months. ISONG would like to acknowledge the University of Pittsburgh and Johns Hopkins University for providing these grants and express appreciation for their ongoing research support.
Application Deadlines
Two deadlines/requirements must be met in order to qualify for the ISONG Research Grant, including:
(1) A letter of intent must be sent via email to Dr. Sandy Founds at safounds@comcast.net
no later than Wednesday July 17, 2013 midnight EST. The letter should include:
- The title of your proposed research
- A brief description (one paragraph maximum) of the research
(2) The full grant proposal and application materials must be sent via email to Dr. Sandy Founds at safounds@comcast.net no later than Tuesday August 13, 2013 midnight EST. Only electronic submissions of the proposals will be accepted. The abstract, proposal narrative, reference section, and appendices must be sent as attachments in MS Word format. The cover page and budget forms must be sent in the format provided at the end of this web page. The attachment must be titled ISONG, year of application, and applicant's last name (Example: ISONG_2013_Mudd).
Please Note: The absence of a letter of intent, an incomplete application, failure to submit a letter of intent and/or application via email, late submission of a letter of intent and/or application, as well as failure to follow application procedures and formatting guidelines will disqualify the applicant. These submissions will not be considered by the ISONG Research Committee.
Application Instructions
A. Submit a letter of intent via email to Dr. Sandy Founds at safounds@comcast.net no later than Wednesday July 17, 2013 midnight EST (midnight EST). The letter should be sent as an attached MS Word document and include:
- A brief description (one paragraph maximum) of the proposed research
B. Submit via email to Research Committee co-chair, Dr. Sandy Founds at safounds@comcast.net no later than Tuesday August 14, 2012 midnight EST one copy of each of the following:
1. Proposal face sheet. The proposal face sheet serves as the cover sheet.
2. Abstract. The abstract is not to exceed one page and must include a problem statement/specific aims; significance of the research including relevance of the study to genetic nursing, and brief statement(s) on methods including sample size, research design, and planned data analysis. This should be submitted as an attached MS Word document.
3. Proposal narrative. The proposal narrative must be no more than 4 pages; narratives exceeding this limit will not be considered. References, appendices, budget, timeline, and biosketches are not counted as part of the 4-page limitation. The proposal narrative should be submitted as an attached MS Word document and should include the following:
- Problem statement/specific aims: Discuss the broad, overall goal(s) and what the specific research proposed in this application is intended to accomplish; state the research questions/aims or hypothesis to be tested.
- Background and significance: Briefly address the background leading to the present application; critically evaluate existing knowledge and identify scientific or methodologic gaps that the project is intended to fill. Identify the importance of the research in terms of its contribution to genetic health nursing and potential for leading to further research. Summarize the theoretical framework as appropriate.
- Research design and methods: Describe the research design and procedures to be used to accomplish the specific aims of the study. Provide a timeline for the project. Include how the data will be collected, analyzed and interpreted. Describe potential study limitations. This section should be organized in the following manner: design (including timeline), setting, sample, procedures, data analysis plan, and limitations.
- References: A reference page or pages should be included at the end of the narrative text. References should be included if cited in the narrative text and should be limited to relevant and current literature. The reference page(s) is (are) not included in the 4-page limitation.
- Appendices: To include research instruments (if applicable), interview guidelines (if applicable), appropriate ethics (Human Subjects/IRB) approval form if available, and letters of support. Support letters must assure the feasibility of the project and that resources are available to complete the study. Please note: If the applicant is a student, a letter of support from the faculty member overseeing the research MUST be included. The appendices are not included in the 4-page limitation.
4. Biosketch. A biosketch or curriculum vitae of the principal investigator should be attached as a MS Word document.
5. Completed budget and budget justification form.
Additional Instructions for Applicants
1. Formatting of proposal narrative and accompanying material.
The following instructions should be strictly adhered:
i. Margins must be no smaller than 0.5" at all points.
ii. Font size must be no smaller than 12 pt. and font type should be Arial or Helvetica.
iii. Abstract, proposal body, reference section, and appendices should be single spaced.
iv. For the abstract, proposal body, reference section, and appendices, use American Psychological Association (APA) formatting.
2. Role of the Principal Investigator
i. All communication from the Research Committee will be with the Principal Investigator.
ii. The Principal Investigator will be responsible for the research project including assurance of scientific and ethical integrity throughout the conduct of the research.
iii. The Principal Investigator will be responsible for completing and sending a final report of the study. The final report is to be sent via email to Dr. Sandy Founds at safounds@comcast.net 90 days following the end of the one-year funding period. The report will be published on the ISONG web site and is to include:
- Summary of project goals/aims
- Theoretical/conceptual framework, if applicable
- Methods: sampling, procedures, and data analysis
- Summary of findings
- Recommendations and brief reflection
- Publications or presentations of abstracts
- Acknowledgement of ISONG funding support
Eligibility Criteria
To be eligible for one of the ISONG grants, an applicant must:
Be a registered nurse with a current license
Be a member of ISONG
Submit a completed research package, including the letter of intent, by the announced deadlines
Be ready to initiate the research project as soon as funding notification is received
Questions?
Questions or a request for additional information may be directed to the Research Committee Co-Chairs:
Sandy Founds: safounds@comcast.net
Nicole Zangrilli Hoh: nmzst1@pitt.edu
Myocarditis Foundation Research Grants
The Myocarditis Foundation is currently accepting applications for Research Grants.
The Myocarditis Foundation (MF) accepts fellowship grant applications on an annual basis for innovative basic, clinical or translational research relevant to the cause or treatment of myocarditis. MF’s fellowship grant program is designed to provide seed funding to investigators for the testing of initial hypotheses and collecting preliminary data to help secure long-term funding by the National Institute of Health (NIH) and other major granting institutions. Funding is available at US $35,000 for salary only.
Grant award decisions are made through a peer review process by our Medical Advisory Board. Scientific excellence and relevance to myocarditis are the basic criteria for selecting the supported research project. The award is designed to support training and career development of physician-scientists in myocarditis research.
Available Funding
The MF research grant provides salary support for 1 year of full-time research. The stipend is $35,000. No additional funds for benefits, travel, or indirect costs, etc. are available.
Eligibility Requirements
Candidates may apply up to 10 years following receipt of an MD, PhD, or an equivalent degree and plan to perform the funded work in the United States or Canada, in order to apply for the Fellowship. All applicants must select a preceptor with a proven track record of research in myocarditis. In addition to providing a letter of recommendation, the preceptor is expected to assist in preparing the application. For applicants wishing advice in the selection of a preceptor, a list of potential preceptors is available from the MF.
Application Procedure
The MF will issue a request for proposals in September of each year. The deadline for grant submission is December 15th with final award decisions made by December 31st. The research plan should be limited to 5 pages and must include the following: hypothesis, specific aims, background/significance, preliminary data, methods and expected results. The applicant should include a cover letter, supporting letter from the preceptor, and applicant and preceptor biographical sketches. Upon receipt of a signed letter of agreement from the selected candidate the MF will disburse the funds in installments during the research year.
Final Report
A final report will be required upon completion of the research year. The Myocarditis Foundation reserves the right to cite the research in all/any of our printed materials and on our website. The Myocarditis Foundation must be acknowledged in all publications resulting from the research.
The Myocarditis Foundation 100 W Main St Utica, MN 55979 Toll-free US & Canada: 1-866-846-1600 Telephone: (732) 295-3700
Request for Application: A-T Children's Project
Attention Researchers:
Request for Application (RFA) for March 1, 2013 and September 1, 2013
Seed funding is now available for innovative proposals that seek to identify and validate biomarkers of A-T disease progression and that can be used to monitor therapeutic efficacy in clinical trials.
Please note that investigator-initiated proposals are also welcome for the March 1 and September 1 grant submission deadlines; however priority will be given to proposals that address the above referenced RFA.
We welcome investigators to contact Cynthia Rothblum-Oviatt, PhD, our Science Coordinator, if help is needed forming collaborations and/or obtaining reagents for A-T/ATM research.
Cynthia Rothblum-Oviatt, PhD Science Coordinator A-T Children's Project 5300 W. Hillsboro Blvd., Suite 105 Coconut Creek, FL 33073 cynthia@atcp.org Phone: 703-765-1223
American Orthopaedic Society for Sports Medicine Sandy Kirkley Clinical Outcome Research Grant
The late Dr. Sandy Kirkley was a passionate advocate for well-conducted randomized controlled trials to evaluate the efficacy of interventions in orthopaedic sports medicine. It was her strong contention that the field must "rise to the challenge of designing and implementing clinical trials that provide the same level of evidence in support of treatments as our nonsurgical colleagues demand." It is one of her intellectual legacies, then, that our profession in general and the Society specifically embrace and support outcome research that has the potential to inform evidence-based practice.
To honor the memory and spirit of Dr. Kirkley, AOSSM established a $20,000 grant that provides start-up, "seed," or supplemental funding for an outcome research project or pilot study. One grant will be awarded each year and eligible applicants are not restricted to newer investigators as is the case for the Young Investigator Grants.
Deadline: December 1, 2013
American Orthopaedic Society for Sports Medicine Young Investigators Grant
The Young Investigator Grant provides awards in amounts of up to $40,000 aimed at providing "seed money," or start-up funds, for pilot projects. The principal investigator must be an early career orthopaedic surgeon, fellow, or resident with interests in sports medicine research. Any investigational team seeking such a grant must include at least one member of AOSSM in good standing.
Pre-reviews: In an effort to improve the quality and competitiveness of submissions, the AOSSM Research Committee will pre-review and critique applications prior to the final application deadline. This pre-review is STRONGLY RECOMMENDED but not required. It is anticipated that by participating in the pre-review process, the applicant's chances for funding will improve.
The pre-review will focus on:
Significance of proposed research
Scientific quality
Statistical methods
Realistic nature of goals
Long term value of results
Pilot data
Pre-Review Deadline: August 15th, 2013. You do not need to include any signatures for pre-review.
Final Deadline: December 1, 2013
Note: Final submission deadline: December 1st before midnight. Please contact Bart Mann with any questions.
American Hearing Research Foundation Regular Grants
The American Hearing Research Foundation funds an average of five research grants each year that investigate various aspects of hearing and balance disorders related to the inner ear. Grants are for $20,000 for one year of research. Priority is given to investigators early in their careers who need seed funds to generate results and data that can be used to support later application for larger grants (i.e., NIH grants) in the future.
AHRF Regular Grants
AHRF grant proposals are due on August 1 of the year before funding begins in January. Proposals are reviewed by the AHRF Research Committee in mid-October and applicants are notified as to the status of their grants immediately. The AHRF uses a five point scale for scoring grants, with one being the highest score and 5 the lowest.
Grant proposals should relate to the hearing or balance functions of the ear. Both basic and clinical studies may be proposed that investigates aspects of the auditory and vestibular systems including but not limited to genetics, neurotology, anatomy, auditory processing, molecular and cellular biology, therapeutic studies, and investigations of current or experimental devices (i.e. cochlear implants).
Applicants should hold the MD, PhD or equivalent degree(s) and be associated with a university or hospital in the United States.
Grant recipients need to submit progress reports by April 1. Reports may be included on our website and/or newsletter. Recipients also must notify the AHRF in advance of any publication of their research funded by the AHRF. Recipients should also notify the AHRF if any aspect of their funded research is reported in the media. It is our goal to highlight research results and publications.
Recipients are also required to submit a final report of their research by the end of January after the completion of their funded year of research.
Grant funds may only be used for direct costs, including salaries of technical and supporting staff, equipment related to the research, and supplies. Funding may not be sued for salary of the principle investigator, travel or conference attendance, or educational costs. No-cost extensions of research past the funded year is granted based on approval of the Research Committee.
American Hearing Research Foundation 8 S. Michigan Ave. Ste. 1205 Chicago, IL 60603 Phone: (312) 726-9670 Fax: (312) 726-9695
American Epilepsy Society Seed Grant Program
This program is intended to foster collaborative interactions between two or more established investigators* to make future grants related to epilepsy more competitive for larger awards, and to fuel multi-investigator projects. These small awards are designed to enable information exchange/technology transfer, travel of postdoctoral fellows between laboratories, and modest supplies for the project.
Criteria:
• At least one PI must be an active member of the Society
• Must be a new initiative that will add value to the field or fill a gap in knowledge
• Techniques in a collaborative effort must be complementary
• Must involve two or more established investigators, at least one of which is an epilepsy-focused investigator.
• Although not required, trans-disciplinary projects, projects integrating clinical and basic research, and research directions with translational relevance are encouraged.
*An established investigator is defined as having at least an Associate Professor or equivalent level appointment, and who has a history of successful NIH/NSF/VA funding. Their work can be focused on basic, translational, or clinical research.
Funding: A maximum of five one-year grants in the amount of $20,000 each will be awarded annually. Grants are non-renewable.
Application Procedures:
Application should be no more than two pages not counting the face page and include:
a) a face page (use this Word document or facsimile)
b) an overview of the research and technical expertise of the participating laboratories/clinical research sites.
c) the research collaboration that is proposed,
d) how the seed grant mechanism will foster this research and the overall collaboration, and
e) a budget.
Applications should also include an NIH format Biosketch for all principal investigators, including present and past funding. This Biosketch should highlight the 5 most significant publications of each investigator published over the past 10 years.
Deadlines
There are three rounds of consideration each year. Applications will be reviewed by a committee of the Research & Training Council and results will be announced within six weeks of the application deadline.
Submission deadlines (no extensions):
• March 29, 2013
• June 29, 2013
• September 30, 2013
Applications (in Word or PDF format) should be sent to the AES Office by email to ctubby@aesnet.org by close of business on the date of the deadline.
123next
